Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2026-01-29 @ 6:17 AM
Study NCT ID:
NCT01404702
Status:
TERMINATED
Last Update Posted:
2014-12-02
First Post:
2011-07-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma
Sponsor:
University of Alabama at Birmingham
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UAB 1051
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None